Literature DB >> 11575298

Trastuzumab and breast cancer.

C Rudlowski, W Rath, A J Becker, O D Wiestler, R Buttner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11575298

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Metastatic male breast cancer: a retrospective cohort analysis.

Authors:  Robert Foerster; Lars Schroeder; Frank Foerster; Volker Wulff; Birgit Schubotz; Dieter Baaske; Christian Rudlowski
Journal:  Breast Care (Basel)       Date:  2014-04       Impact factor: 2.860

2.  Male Breast Cancer.

Authors:  Christian Rudlowski
Journal:  Breast Care (Basel)       Date:  2008-06-24       Impact factor: 2.860

Review 3.  HER2-positive male breast cancer: an update.

Authors:  Laura Ottini; Carlo Capalbo; Piera Rizzolo; Valentina Silvestri; Giuseppe Bronte; Sergio Rizzo; Antonio Russo
Journal:  Breast Cancer (Dove Med Press)       Date:  2010-10-04

4.  A case of HER2-positive male occult breast carcinoma with skin and lymph node metastases that exhibited complete response to trastuzumab monotherapy.

Authors:  Kouichi Kuninaka; Ryo Takahashi; Yutaka Nakagawa; Tadashi Nishimaki
Journal:  Clin Case Rep       Date:  2017-03-17

5.  Effects of HER2 status on the prognosis of male breast cancer: a population-based study.

Authors:  Liang Chen; Yi Ming Weng; Meng Xue Hu; Min Peng; Qi Bin Song
Journal:  Onco Targets Ther       Date:  2019-09-05       Impact factor: 4.147

Review 6.  Management of Male Breast Cancer: The Journey so Far and Future Directions.

Authors:  Quratulain Anna Sabih; Jessica Young; Kazuaki Takabe
Journal:  World J Oncol       Date:  2021-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.